Swiss - Delayed Quote CHF

SHL Telemedicine Ltd. (SHLTN.SW)

Compare
2.6000
0.0000
(0.00%)
As of 11:11:01 AM GMT+1. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
57,075.0000
57,075.0000
58,998.0000
49,582.0000
40,164.0000
Cost of Revenue
31,814.0000
31,814.0000
31,809.0000
24,989.0000
19,520.0000
Gross Profit
25,261.0000
25,261.0000
27,189.0000
24,593.0000
20,644.0000
Operating Expense
32,069.0000
32,069.0000
31,939.0000
24,542.0000
19,699.0000
Operating Income
-6,808.0000
-6,808.0000
-4,750.0000
51.0000
945.0000
Net Non Operating Interest Income Expense
-509.0000
-509.0000
-865.0000
-465.0000
-522.0000
Other Income Expense
1,353.0000
1,353.0000
6,927.0000
-13,055.0000
-346.0000
Pretax Income
-5,964.0000
-5,964.0000
1,312.0000
-13,469.0000
77.0000
Tax Provision
891.0000
891.0000
1,097.0000
455.0000
-201.0000
Net Income Common Stockholders
-7,056.0000
-7,056.0000
-76.0000
-14,110.0000
278.0000
Diluted NI Available to Com Stockholders
-7,056.0000
-7,056.0000
-76.0000
-14,110.0000
278.0000
Basic EPS
-0.43
-0.43
-0.01
-1.00
0.03
Diluted EPS
-0.54
-0.54
-0.49
-1.00
0.03
Basic Average Shares
16,269.0000
16,269.0000
14,542.0000
14,110.0000
10,503.0000
Diluted Average Shares
16,295.0000
16,295.0000
15,198.0000
14,110.0000
10,504.0000
Total Operating Income as Reported
-9,006.0000
-9,006.0000
-5,166.0000
-497.0000
396.0000
Rent Expense Supplemental
1,406.0000
1,406.0000
1,284.0000
1,277.0000
827.0000
Total Expenses
63,883.0000
63,883.0000
63,748.0000
49,531.0000
39,219.0000
Net Income from Continuing & Discontinued Operation
-7,056.0000
-7,056.0000
-76.0000
-14,110.0000
278.0000
Normalized Income
-8,839.3200
-8,839.3200
-5,730.1100
-3,934.4500
158.6500
Interest Income
1,055.0000
1,055.0000
429.0000
376.0000
104.0000
Interest Expense
1,296.0000
1,296.0000
1,033.0000
529.0000
405.0000
Net Interest Income
-509.0000
-509.0000
-865.0000
-465.0000
-522.0000
EBIT
-4,668.0000
-4,668.0000
2,345.0000
-12,940.0000
482.0000
EBITDA
3,024.0000
3,024.0000
9,479.0000
-7,558.0000
5,410.0000
Reconciled Cost of Revenue
27,064.0000
27,064.0000
28,192.0000
22,010.0000
16,690.0000
Reconciled Depreciation
7,692.0000
7,692.0000
7,134.0000
5,382.0000
4,928.0000
Net Income from Continuing Operation Net Minority Interest
-7,056.0000
-7,056.0000
-76.0000
-14,110.0000
278.0000
Total Unusual Items Excluding Goodwill
2,316.0000
2,316.0000
7,343.0000
-13,215.0000
155.0000
Total Unusual Items
2,316.0000
2,316.0000
7,343.0000
-13,215.0000
155.0000
Normalized EBITDA
708.0000
708.0000
2,136.0000
5,657.0000
5,255.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
532.6800
532.6800
1,688.8900
-3,039.4500
35.6500
12/31/2020 - 11/15/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

OMDA.OL Omda AS
37.00
+2.21%
 
GPI.MI GPI S.p.A.
10.18
-0.39%
 
ALC.AX Alcidion Group Limited
0.0660
-2.94%
 
COP.DE CompuGroup Medical SE & Co. KGaA
22.46
+0.81%
 
BTSGU BrightSpring Health Services, Inc.
75.66
+1.79%
 
AIFORIA.HE Aiforia Technologies Oyj
3.5600
+2.30%
 
RAY-B.ST RaySearch Laboratories AB (publ)
227.00
-0.66%
 
MOSS.CN Moss Genomics Inc.
0.2300
0.00%
 
WGSWW GeneDx Holdings Corp.
0.2155
+7.75%
 
EUDA EUDA Health Holdings Limited
3.7300
-0.80%